- Home
- PLAG vs LPCN Comparison
PLAG vs LPCN Comparison
Compare PLAG & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- LPCN
- Stock Information
- Founded
- PLAG 1986
- LPCN 1997
- Country
- PLAG United States
- LPCN United States
- Employees
- PLAG N/A
- LPCN N/A
- Industry
- PLAG Packaged Foods
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- PLAG Consumer Staples
- LPCN Health Care
- Exchange
- PLAG Nasdaq
- LPCN Nasdaq
- Market Cap
- PLAG 18.9M
- LPCN 19.4M
- IPO Year
- PLAG N/A
- LPCN N/A
- Fundamental
- Price
- PLAG $2.27
- LPCN $3.38
- Analyst Decision
- PLAG
- LPCN Strong Buy
- Analyst Count
- PLAG 0
- LPCN 1
- Target Price
- PLAG N/A
- LPCN $10.00
- AVG Volume (30 Days)
- PLAG 5.7K
- LPCN 33.0K
- Earning Date
- PLAG 03-31-2025
- LPCN 03-06-2025
- Dividend Yield
- PLAG N/A
- LPCN N/A
- EPS Growth
- PLAG N/A
- LPCN N/A
- EPS
- PLAG N/A
- LPCN N/A
- Revenue
- PLAG $16,965,260.00
- LPCN $7,922,926.00
- Revenue This Year
- PLAG N/A
- LPCN N/A
- Revenue Next Year
- PLAG N/A
- LPCN N/A
- P/E Ratio
- PLAG N/A
- LPCN N/A
- Revenue Growth
- PLAG N/A
- LPCN N/A
- 52 Week Low
- PLAG $1.18
- LPCN $3.20
- 52 Week High
- PLAG $5.52
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- PLAG 44.18
- LPCN 30.99
- Support Level
- PLAG $2.24
- LPCN $3.42
- Resistance Level
- PLAG $2.47
- LPCN $3.62
- Average True Range (ATR)
- PLAG 0.17
- LPCN 0.26
- MACD
- PLAG -0.02
- LPCN -0.02
- Stochastic Oscillator
- PLAG 10.98
- LPCN 1.61
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.